The FDA approved re-administration of iDose TR for patients with healthy corneas, enhancing treatment flexibility for ...

New 2026 cannabis bills in Mississippi, Hawaii, and Nebraska reveal the next wave of drug testing challenges for employers.

The FDA has approved a label update for an inhaled insulin indicated for adults with type 1 or type 2 diabetes, according to ...

The FDA approved a larger nelarabine vial to improve dosing flexibility and simplify treatment for adult and pediatric ...

The FDA approved Darzalex Faspro with Velcade, Revlimid and dexamethasone for newly diagnosed multiple myeloma ineligible for ...

CTK recently completed FDA OTC registration and related compliance steps for three white-label suncare products: a sun lotion ...

The FDA has approved the first dual-agent eye drop to treat presbyopia, a condition that causes gradual loss of near vision in adults.

Discover how rimegepant (Nurtec ODT) works for both migraine treatment and prevention. Learn about the approved age range, ...

FDA refused to approve Corcept’s Relacorilant for hypercortisolism in December, citing insufficient proof of effectiveness.

Once-daily carbachol/brimonidine tartrate significantly improves aging-related vision loss ...